New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Students seeking admission to undergraduate courses in Odisha for the 2026–27 academic session have…
Bhubaneswar: In an effort to showcase and promote Odisha's rich handloom and handicraft traditions, a…
Bhubaneswar: Efforts to improve access to government welfare schemes for vulnerable urban communities received a…
Bhubaneswar: The Odisha Electricity Regulatory Commission (OERC) on Tuesday welcomed a new member with the…
Bhubaneswar: The Odisha government has set a March 2027 deadline for the completion of all…
Bhubaneswar: The West Bengal government on Tuesday announced that the word “Dham” will no longer…
